← Leaderboards
Donald R Smith
University Of California Santa Cruz
$8,882,380
Attributed
$12,233,273
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–23$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$12,233,273 · 5
By mechanism
R01$11,963,273 · 4
R56$270,000 · 1
Top collaborators
- Roberto G Lucchini11 shared
- Robert O Wright6 shared
- Megan K Horton1 shared
Most similar at University Of California Santa Cruz
Same institution · by research overlap
- Roberto G Lucchini$4,339,191
- Theodore R Holman$8,552,369
Others in their field
Top investigators on “Manganese”
- Robert O Wright · Brigham And Women'S Hospital$37,813,410
- Rosalind J Wright · Icahn School Of Medicine At Mount Sinai$30,980,110
- Joseph H Graziano · Columbia University Health Sciences$17,774,802
- Vera Hoffman · Reveal Pharma$15,740,450
- Brad A Racette · Washington University$15,427,995
- Aaron B Bowman · Vanderbilt University Medical Center$11,887,905
Research focus
ManganeseLifeLinkChildChildhoodDesignBaseNeurobehavioralBrainAttentionBehaviorPrefrontal CortexEarly Life ExposureDoseHairCognitiveCoupledHealth PolicyAreaBloodExposure ToGuidelinesAnimalsBiological
Grant awards (29)
Mechanisms and therapies for the neurobehavioral deficits from early Mn exposure$386,440
R01 · FY2023 · ES · contact PI
Mechanisms and therapies for the neurobehavioral deficits from early Mn exposure$551,255
R01 · FY2021 · ES · contact PI
Mechanisms and therapies for the neurobehavioral deficits from early Mn exposure$585,062
R01 · FY2020 · ES · contact PI
Manganese Exposure Windows and Neurologic Function in Adolescence$582,771
R01 · FY2020 · ES
Mechanisms and therapies for the neurobehavioral deficits from early Mn exposure$596,148
R01 · FY2019 · ES · contact PI
Manganese Exposure Windows and Neurologic Function in Adolescence$583,013
R01 · FY2019 · ES
Mechanisms and therapies for the neurobehavioral deficits from early Mn exposure$142,847
R01 · FY2019 · ES · contact PI
Mechanisms and therapies for the neurobehavioral deficits from early Mn exposure$571,410
R01 · FY2018 · ES · contact PI
Manganese Exposure Windows and Neurologic Function in Adolescence$546,446
R01 · FY2018 · ES
Manganese Exposure Windows and Neurologic Function in Adolescence$559,518
R01 · FY2017 · ES
Manganese Exposure Windows and Neurologic Function in Adolescence$391,320
R01 · FY2016 · ES
Manganese Exposure Windows and Neurologic Function in Adolescence$270,000
R56 · FY2015 · ES
Neurologic function in children exposed to ambient manganese$523,026
R01 · FY2014 · ES · contact PI
Neurobehavioral Impacts of Early Mn Exposures$295,594
R01 · FY2014 · ES · contact PI
Neurologic function in children exposed to ambient manganese$555,974
R01 · FY2013 · ES · contact PI
Neurobehavioral Impacts of Early Mn Exposures$480,247
R01 · FY2013 · ES · contact PI
Neurologic function in children exposed to ambient manganese$35,000
R01 · FY2013 · ES · contact PI
Neurologic function in children exposed to ambient manganese$546,925
R01 · FY2012 · ES · contact PI
Neurobehavioral Impacts of Early Mn Exposures$508,154
R01 · FY2012 · ES · contact PI
Neurobehavioral Impacts of Early Mn Exposures$32,063
R01 · FY2012 · ES · contact PI
Neurologic function in children exposed to ambient manganese$536,162
R01 · FY2011 · ES · contact PI
Neurobehavioral Impacts of Early Mn Exposures$510,337
R01 · FY2011 · ES · contact PI
Neurologic function in children exposed to ambient manganese$593,942
R01 · FY2010 · ES · contact PI
Neurobehavioral Impacts of Early Mn Exposures$507,274
R01 · FY2010 · ES · contact PI
Neurobehavioral Impacts of Early Mn Exposures$34,807
R01 · FY2010 · ES · contact PI
Role of Manganese in Neurodegenrative Disease$259,441
R01 · FY2005 · ES
Role of Manganese in Neurodegenrative Disease$324,989
R01 · FY2004 · ES
Role of Manganese in Neurodegenrative Disease$357,052
R01 · FY2003 · ES
Role of Manganese in Neurodegenrative Disease$366,056
R01 · FY2002 · ES